ArticleBMC oral health2026
Association between calcitonin gene-related peptide and substance P in saliva and pulp according to anxiety levels in patients with dental pain: a cross-sectional study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07330024 (Evaluation of Salivary and Pulpal Levels of Substance P and Calcitonin Gene-Related Peptide in Relation to Dental Pain, Pulpal Inflammation, and Psychological Status), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of Salivary and Pulpal Levels of Substance P and Calcitonin Gene-Related Peptide in Relation to Dental Pain, Pulpal Inflammation, and Psychological Status
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDental pain is influenced by both local inflammatory processes and neurobiological and psychological factors. This study compared substance P (SP) and calcitonin gene-related peptide (CGRP) levels in pulp tissue and unstimulated saliva between patients with dental pain and painless controls, and investigated their relationships with pain severity, pulpal inflammation, and psychological distress.
methodsFifty-two adult patients indicated for primary endodontic treatment were enrolled and allocated into two groups: 26 patients with dental pain and 26 painless controls with no pain complaint and a VRS score of 0. Pain intensity was assessed using the Verbal Rating Scale (VRS). Depression, anxiety, and stress were evaluated using the Depression Anxiety Stress Scale-21 (DASS-21). Pulp tissue and unstimulated saliva samples were collected and analyzed using enzyme-linked immunosorbent assay. Pulpal inflammation was graded histopathologically. Between-group comparisons were performed using independent samples t-tests or Mann-Whitney U tests, as appropriate. Effect sizes were calculated using eta squared (η²). Correlations were assessed using Pearson or Spearman coefficients to examine associations between neuropeptide levels, pain severity, and inflammation grade.
resultsPulp calcitonin gene-related peptide levels were significantly higher in patients with dental pain than in painless controls (p = 0.007; η² = 0.146). Salivary substance P levels were also significantly increased in the painful group (p = 0.044; η² = 0.080). No significant between-group differences were observed for pulp substance P or salivary calcitonin gene-related peptide (p > 0.05). Depression, anxiety, and stress scores were all significantly higher in patients with dental pain (all p < 0.001). Pain severity showed positive correlations with pulp calcitonin gene-related peptide (r = 0.332) and salivary substance P (r = 0.324), whereas no significant association was found between pain severity and histopathological inflammation grade.
conclusionsPulp calcitonin gene-related peptide may be associated with local neurogenic activation in symptomatic pulpal pain, while salivary substance P may represent a potential noninvasive candidate marker for pain-associated responses. However, the lack of consistent pulp-saliva correspondence indicates that salivary biomarkers should not be considered direct surrogates of pulpal neuropeptide activity.
trial registrationClinicalTrials.gov Identifier: NCT07330024.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.